Co-Amoxiclav Oral Suspension Manufacturer in India

Product Overview
Key Features
Therapeutic Uses
Dosage Form Advantages

Genliva Wellness LLP formulates Co-Amoxiclav Oral Suspension for pediatric bacterial infections where broader antibacterial protection is required against resistant organisms. The formulation is regularly administered in tonsillitis, otitis media, sinusitis, bronchial infections, and recurrent throat bacterial conditions in children.

The combination of Amoxicillin and Clavulanic Acid delivers antibacterial activity against susceptible pathogens while counteracting beta-lactamase enzyme-mediated resistance. The oral suspension format allows flexible pediatric dosing and convenient administration in younger age groups requiring liquid antibiotic therapy.

As a leading Co-Amoxiclav Oral Suspension Manufacturer in India, Genliva Wellness LLP supplies pediatric antibacterial formulations for pharmaceutical distributors, pediatric healthcare suppliers, private labeling companies, and export-oriented medicine markets.

Co-Amoxiclav Oral Suspension is developed for pediatric resistant bacterial infection management.

Pediatric amoxicillin and clavulanate combination
Frequently utilized in ENT bacterial infections
Oral liquid formulation for flexible dosing
Enhanced antibacterial action against resistant organisms
Manufactured under WHO GMP quality standards
Intended for pediatric antibacterial therapies

This formulation is prescribed in pediatric respiratory and bacterial infection treatment.

Treatment of tonsillitis and throat infections
Management of otitis media and sinusitis
Administered in pediatric bronchial infections
Utilized in recurrent bacterial conditions
Targets beta-lactamase producing bacteria
Frequently selected in pediatric outpatient care

Co-Amoxiclav Oral Suspension delivers broader antibacterial protection for pediatric infections.

Valuable in recurrent ENT infection treatment
Convenient liquid administration for children
Extended antibacterial coverage in resistant conditions
Frequently preferred in pediatric respiratory care
Effective oral antibiotic option for younger patients
Maintains strong antibacterial combination performance